Who
Anne Clem Whitaker
Director
Company insider
Files Form 4 as: Director, Alkermes; Director, Icon; Director, OraSure Technologies; Director, Lisata Therapeutics; Director, Mallinckrodt; Director, Wolfspeed; EVP, Company Group Chairman, Bausch Health Companies; President and CEO, Madrigal Pharmaceuticals.
In numbers
- Trades disclosed
- 62
- Buys
- 1
- Sells
- 6
- Bought
- $1.8M
- Sold
- $2.4M
- Companies
- 8
- Companies where not an officer
- 6
- First trade
- 2 Dec 2013
- Last trade
- 7 Oct 2026
- Last filed
- 9 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 7 Oct 2026filed 9 Oct 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —7,239 at $0.00 | filing |
| 7 Oct 2026filed 9 Oct 2026 | ALKS Alkermesoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —17,998 at $0.00 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $14K88 at $162.72 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $16K96 at $163.77 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $97K590 at $164.47 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $11K67 at $165.51 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $14K88 at $162.72 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $16K96 at $163.77 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $97K590 at $164.47 | filing |
| 11 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Sold | $11K67 at $165.51 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Code M | —1,732 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,732 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,324 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code M | —1,732 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR Iconoption or derivative · Life-science tools | SEC FORM 4 Code A | —1,324 at $0.00 | filing |
| 10 Aug 2026filed 12 Aug 2026 | ICLR IconLife-science tools | SEC FORM 4 Code M | —1,732 | filing |
| 16 May 2023filed 17 May 2023 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $12K2,323 at $5.30 | filing |
| 15 May 2023filed 17 May 2023 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code F | $25K4,400 at $5.62 | filing |
| 16 May 2022filed 18 May 2022 | OSUR OraSure TechnologiesMedical Devices | SEC FORM 4 Code A | $105K20,000 at $5.25 | filing |
| 10 Jan 2022filed 12 Jan 2022 | LSTA Lisata TherapeuticsBiotechnology | SEC FORM 4 Code A | —65,430 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.